<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Several psychotomimetic phencyclidine (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e>) analogs--N-ethyl-l-phenylcyclohexylamine (PCE), N-[1-(<z:chebi fb="0" ids="35849">2-thienyl</z:chebi>)<z:chebi fb="0" ids="52552">cyclohexyl</z:chebi>]<z:chebi fb="0" ids="18049">piperidine</z:chebi> (TCP), N-[1-(<z:chebi fb="0" ids="37991">thienyl</z:chebi>)<z:chebi fb="0" ids="52552">cyclohexyl</z:chebi> ))<z:chebi fb="0" ids="33135">pyrrolidine</z:chebi> (<z:chebi fb="0" ids="46941">THP</z:chebi>), ketamine, and N,N-dimethyl-l-<z:chebi fb="1" ids="30396">phenyl</z:chebi>-<z:chebi fb="0" ids="15773">cyclohexylamine</z:chebi> (PCDEA)--were tested on basilar and middle cerebral arteries of the dog in vitro and found to induce contraction in these blood vessels with a maximal contractile activity (i.e., intrinsic activity) similar to that of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The concentration-effect curves of these compounds were found to be parallel to the curve of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e> (P less than 0.01) </plain></SENT>
<SENT sid="2" pm="."><plain>The relative potency was PCE greater than TCP greater than <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e> greater than <z:chebi fb="0" ids="46941">THP</z:chebi> greater than PCDEA greater than ketamine </plain></SENT>
<SENT sid="3" pm="."><plain>A <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e> analog with no psychotomimetic activity, 1-piperidinocyclohexanecarbonitrile (PCC), did not induce the blood vessels to contract, nor did the opiate <z:chebi fb="71" ids="17303">morphine</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Three psychotomimetic benzomorphans--pentazocine, cyclazocine, and N-allylnorcyclazocine--were found to: (i) also produce contraction; and (ii) have concentration--effect curves parallel to the curve of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e>, but with reduced intrinsic activities (i.e., maximal tensions were lowered) compared to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>A kappa opiate, ethylketocyclazocine, relaxed the blood vessels in a dose-dependent manner </plain></SENT>
<SENT sid="6" pm="."><plain>This study provides direct evidence for a distinct <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e> receptor on cerebral blood vessels and suggests that certain benzomorphans may produce <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> via <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e>-receptor interactions </plain></SENT>
</text></document>